ISNO > News > Start DeManDII study Duchenne Muscular Dystrophy in RUNMC
Print Mail
News
Start DeManDII study Duchenne Muscular Dystrophy in RUNMC
26 October 2010

UMC St Radboud in Nijmegen will start in November 2010 with the DeManDII study. It is a dose comparing study for exon 51 skipping in Duchenne Muscular Dystrophy patients.

A double blind placebo controlled comparison is made between:
1) a continuous weekly injection and
2) intermittent schedule of 10 weeks:  1 injection in week 1,3,5, and  2 injections in week 2,4,6, followed by 4 weeks no injection
3) placebo injection

The study will start in ten centres worldwide including: 2 centres in UK, 2 in Spain, 2 in Australia, 1 in France, 1 in Belgium, 1 in Germany, 1 in Turkey, and 1 in the Netherlands.

The whole study period will take 48 weeks, results are expected in 2012.

News item?

If you have a news item for the ISNO website, please mail us